For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of C4 Therapeutics Inc (NASDAQ: CCCC) closed at $3.92 in the last session, up 7.10% from day before closing price of $3.66. In other words, the price has increased by $7.10 from its previous closing price. On the day, 0.8 million shares were traded. CCCC stock price reached its highest trading level at $3.98 during the session, while it also had its lowest trading level at $3.67.
Ratios:
We take a closer look at CCCC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.31 and its Current Ratio is at 6.31. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Upgraded its rating to Overweight and sets its target price to $12 from $8 previously.
On November 18, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $4.
JP Morgan Upgraded its Underweight to Neutral on January 29, 2024, while the target price for the stock was maintained at $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Salter Malcolm bought 13,000 shares for $4.19 per share.
Salter Malcolm bought 13,000 shares of CCCC for $83,321 on Oct 18 ’24. On Oct 11 ’24, another insider, Salter Malcolm, who serves as the Director of the company, bought 8,561 shares for $5.38 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCCC now has a Market Capitalization of 276708896 and an Enterprise Value of 88162720. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.80 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 2.619 whereas that against EBITDA is -0.766.
Stock Price History:
Over the past 52 weeks, CCCC has reached a high of $11.88, while it has fallen to a 52-week low of $3.43. The 50-Day Moving Average of the stock is -16.09%, while the 200-Day Moving Average is calculated to be -31.52%.
Shares Statistics:
According to the various share statistics, CCCC traded on average about 1.31M shares per day over the past 3-months and 2104070 shares per day over the past 10 days. A total of 70.56M shares are outstanding, with a floating share count of 56.92M. Insiders hold about 19.37% of the company’s shares, while institutions hold 83.30% stake in the company. Shares short for CCCC as of 1734048000 were 8869471 with a Short Ratio of 6.79, compared to 1731628800 on 7401252. Therefore, it implies a Short% of Shares Outstanding of 8869471 and a Short% of Float of 15.22.
